OP
INBS icon

ORG Partners’s Intelligent Bio Solutions INBS Stock Holding History

ORG Partners’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-42
Closed -$5.15K – 1241
2023
Q3 		$5.15K Buy
+42
New +$9.53K ﹤0.01% 943

Other funds holding INBS

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

ORG Partners's INBS Position: Q4 2023 in Review

ORG Partners sold out of Intelligent Bio Solutions (INBS) in Q4 2023, closing a stake of 42 shares — an estimated $5.15K sold.

ORG Partners first reported a position in INBS in Q3 2023 and held it in 1 quarter. The position peaked at $5.15K in Q3 2023. 8 funds tracked by Wall St. Rank hold INBS as of Q4 2023.

  • ORG Partners reported no remaining Intelligent Bio Solutions position as of Q4 2023 after selling out during the quarter.
  • ORG Partners sold 42 Intelligent Bio Solutions shares in Q4 2023, an estimated $5.15K.
  • ORG Partners first reported a position in Intelligent Bio Solutions in Q3 2023 and held it in 1 quarter.
  • ORG Partners's Intelligent Bio Solutions position peaked at $5.15K in Q3 2023.
  • 8 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q4 2023.

Based on ORG Partners's 13F filing for Q4 2023, filed 29 Jan 2024.